SpotlightSpotlight
NeutralNeutral Sentiment

POET Past $15: Lumilens Lands, Shorts Bring the Wrong Photos

9 min read|Monday, May 18, 2026 at 9:21 AM ET
POET Past $15: Lumilens Lands, Shorts Bring the Wrong Photos

Share this article

Spread the word on social media

When we wrote about POET’s $15 wall last Tuesday, the question was binary: would price, volume, and time converge before May 15 expiration, or would the 20,308 contracts at the $15 strike expire as theta cooked them to zero?

Five trading days later, the answer is in. The trigger fired. The wall broke. The move ran further and faster than the strike-by-strike map suggested, and exactly as forecast, the rolls planted fresh positioning into May 22, May 29, and June where the next round of dealer hedging now sits.

Then Friday happened. A $50M purchase order with a five-year framework to $500M. A $400M registered direct offering closing into the move. And—almost on schedule with the financing—a short report from Night Market Research, complete with photographs of an office that isn’t even POET’s, amplified by the usual coordinated cluster of bot accounts that always seem to wake up at the same time. Let’s walk it.

The wall cracked, and it cracked through every shelf above it

Thursday May 14, POET announced a supply and joint development agreement with Lumilens—initial $50M purchase order, framework to more than $500M over five years. POET gapped through $15 on the bell, drove through $18, and tagged a session high of $20.81 intraday. An 11-year high.

The dealer math sketched in the original article played out line by line. Calls at the $15 strike that opened the week with deltas of 0.25–0.35 finished Thursday deep in the money at 0.95+. The combined $15/$18/$20 open interest above spot—roughly 32,000 contracts, share-equivalent of about 3.2 million shares—created a hedging staircase that compounded into the close. Call volume on Thursday ran into the hundreds of thousands across the chain. Implied volatility re-rated. Textbook.

Friday was the unwind. Q1 results posted $503,389 in revenue (up 194% year-over-year, ahead of consensus by roughly $250K) and $429M in cash and short-term investments. POET also announced a $400M registered direct offering to a single institutional investor—19,047,620 units at $21.00, each unit one common share plus a three-year warrant exercisable at $26.15. Pro forma cash position runs near $830M.

POET closed Friday at $15.97, off 22% from Thursday’s $20.57 on volume near 100 million shares—roughly $1.6B in dollar volume. Monday pre-market opened the rebound, with shares running +11% as traders positioned ahead of Nvidia earnings later in the week.

The wall worked exactly as a wall works when the trigger pulls: launchpad on the way up, temporary ceiling on the way back down.

The Lumilens deal—what was actually announced

The headline is $50M initially, scaling to $500M+ over five years. The mechanics underneath the headline matter more than either number in isolation.

The $50M is a committed initial purchase order for EOI-based optical engines. Engineering samples are scheduled for late 2026, production ramp aligned to hyperscaler deployments in 2027. Lumilens received a warrant to purchase up to 22,921,408 common shares of POET at an exercise price of $8.25 per share, exercisable over nine years. Only 2,292,140 shares are immediately exercisable. The remaining shares vest in tranches as Lumilens makes cumulative payments toward future purchase orders totaling up to $500M.

That structure is the point. Lumilens does not unlock the bulk of the warrant by signing a piece of paper. Lumilens unlocks it by actually paying POET for product. The warrant is not free optionality on POET’s float—it is performance-locked equity tied to revenue conversion. The framing that POET handed Lumilens free shares for a press release is not what the agreement says. You’d think a research firm with “Research” in the name would have read the agreement.

The short report that hit on the same day the financing closed

Friday morning, Night Market Research published a short report on POET. The timing alone tells you most of what you need to know—same trading session as the $400M financing was announced. Coincidences like that happen about as often as my dog files a 10-K.

This is the third short report on POET in two months. Wolfpack in April on PFIC. Now Night Market on… the same PFIC concerns POET already addressed in its March 31 disclosure, the same dilution complaints that pre-date the company’s announced U.S. headquarters relocation (which directly remediates the PFIC structure), and a new set of unverifiable conversations with anonymous executives at OFC 2026 that, by construction, cannot be checked by anyone, ever. Convenient. This tactic is nothing new to the stock market or POET. Shorts get behind, they double down, they get behind even more that throw Hail Marys & right now they are praying to baby Jesus himself or anyone that will listen.

A few of the specific claims deserve a direct response.

The “POET HQ is abandoned” claim.

The report and its social rollout feature photographs of what Night Market presents as POET’s Toronto headquarters—empty rooms, a whiteboard covered in cartoon faces, a trashed-looking office. The offices in those photographs are not POET’s headquarters. Not POET’s space, not POET’s floor, not the company’s actual administrative footprint. A short seller photographing a random office and presenting it as the issuer’s HQ is not research. It’s a prop. And once that prop is exposed, the rest of the “we visited and saw” sourcing standard has to be read in the same light. Even if this was the HQ (which it’s not) the only people in it would be administrative like a lawyer, accountant and a secretary as an example. This is as they say “not where the sausage is made.”

The LITEON quote. Night Market quotes LITEON’s president saying “LITEON doesn’t cooperate with [POET]” and “there isn’t actual business between us.” The quote is lifted from a Q1 earnings call response to a question about whether LITEON would be affected by POET’s Marvell-Celestial cancellation. The president was distinguishing LITEON from the canceled Marvell deal, not denying the existence of the joint development agreement POET and LITEON announced in March and that LITEON itself referenced in its own Q1 release. Lifting six words from a thirty-second answer about a different counterparty and presenting it as a denial of the whole partnership is the kind of editing that only works on people who won’t pull up the original recording.

The “dead partnerships” claim. Anonymous executives at OFC 2026—Foxconn, Luxshare, Mitsubishi, Adtran, Semtech, Multilane. None named. None sourced. No way for anyone to verify the speaker existed, was in a position to know, or said what’s attributed to them. Combined with the misidentified HQ photographs, the report is a structure designed to be unfalsifiable.

The Lumilens “incestuous promotion” claim. The interpretation that Lumilens has no intention of buying anything from POET has to confront the warrant structure: the vast majority of the warrant only unlocks if Lumilens actually pays POET. There is no mechanism in the agreement by which Lumilens collects free shares for a press release. None.

The amplification pattern.

Within an hour of the report dropping, the same coordinated cluster of accounts that surfaced for Wolfpack surfaced again—same low-follower profiles, same near-identical phrasing, same Asian-timezone posting cadence, same handoff structure between accounts. Bot networks exaggerating and overreaching on already-public information do not constitute new information. They constitute a campaign.

Which gets at what’s really going on. Short sellers got run over from $3.87 to $20.81 in six weeks. Some of them are deeply underwater. When shorts are desperate, they don’t get more careful—they get less careful, because the only thing that gets them out at break-even is a coordinated push to scare retail into selling. Fabricated office photos, clipped quotes, anonymous “executives,” bot amplification—that’s not a thesis, that’s a hostage negotiation.

We give balanced coverage of POET and acknowledge $POET still has to commercialize & execute on strategy, which can be said for any company in this AI data center super cycle providing “picks & shovels.” The $500M Lumilens framework is a framework, not a backlog. Engineering samples ship in late 2026. The 2027 production ramp is the year that matters. Q1 revenue was half a million dollars. These are real facts the bear case can build on without fabricated photographs, mischaracterized earnings-call quotes, or rented Twitter accounts. Night Market chose the recycled version.

Where the gamma story goes from here

The May 22 $14 strike carried 2,605 contracts of open interest a week ago and is now the active battleground for the short-dated chain. The May 29 chain absorbed a meaningful slice of the rolls out of the May 15 $15s, rebuilding the gamma footprint a week further out at $17, $20, and $22. The June expiration is now anchored around $20 and $25, with the financing’s $26.15 warrant strike adding a third magnetic level that will absorb hedging flow for years.

Catalysts: Nvidia’s Q1 earnings Wednesday. POET has no commercial relationship with Nvidia, but Nvidia’s commentary on photonic interconnect has been a sympathy driver for the optical names every quarter, and POET specifically has shown high beta to any photonics mention. Beyond Wednesday, OFC Asia in late June and hyperscaler product cycle announcements are the next price-moving events.

The bottom line

The $15 wall did what gamma walls do when the trigger arrives—launchpad, not ceiling. The Lumilens framework replaces the Marvell-Celestial overhang with a structurally aligned counterparty whose economics require it to actually pay for product. The $400M financing addresses the cash question for years rather than quarters. And the short report that hit the same day the financing closed leans on photographs of an office that isn’t POET’s, quotes from unnamed conference attendees, and a bot cluster posting from time zones that should have been asleep.

POET is not going anywhere. Shorts are. The real bear case is execution risk on the 2027 ramp—that’s the conversation worth having. Last Friday’s report wasn’t it.

Three trading days became five. The wall became a launchpad. The next chain is loaded.

$POET $POEL $NVDA $AMD $COHR $LITE

Poet stockshort reportgamma squeezelumilensUnusual whalesphotonicspoet technologies

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Discover More Insights

Get curated market analysis and editorial deep dives from our team. The stories that matter most, examined from every angle.

More Spotlight Articles

Compensation Disclosure: Jefferson Equity Derivatives & Intelligence LLC has been compensated for the promotion of POET Technologies Inc. (NASDAQ: POET). POET Technologies Inc. paid three hundred twenty thousand dollars ($320,000) USD Cash for a marketing program (March 1, 2026 through December 31, 2026). As a result, our opinion is neither unbiased nor independent. The publishers hold no securities of the Company. This marketing may increase investor awareness, trading volume, and share price, which may be temporary. Full disclaimers.

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.